Toronto – October 3, 2023 – The Canadian Nuclear Isotope Council (CNIC) is excited to welcome Serva Energy, a nuclear innovation company based in Arizona, as its newest member. Serva specializes in innovations in isotope technologies including a novel Ac-225 production method. As an American company branching into the growing Canadian isotope market, Serva is looking to provide companies across Canada with the tools needed to produce isotopes for novel cancer treatments.
In June 2023, Serva announced the development of a new reactor-based production method to ramp up the supply of actinium-225 (Ac-225), using a conventional nuclear reactor to produce significantly greater quantities of the isotope. Serva’s technology transforms radium-226 isotopes, previously considered radioactive waste, into life-saving Ac-225. This innovation allows for dozens of existing reactors around the world to collaborate with Serva to dramatically increase the production of Ac-225.
Building on this initial success, Serva is looking to engage with Canadian partners to leverage and develop new technologies in the field of isotope production.
“To overcome existing and future supply challenges, we must work as a global isotope community to develop solutions to ensure that patients around the world can benefit from revolutionary cancer treatments,” said James Scongack, Chair of the CNIC. “The CNIC was formed to facilitate these types of international connections and encourage global partnerships with the Canadian isotope industry. These partnerships will further enable innovation within the industry and ensure a secure supply of isotopes to fuel clinical trials and essential health research here in Canada.”
“We are excited about this partnership and its potential to deliver critical solutions and supplies to the radiopharmaceutical industry” said Ian Horvath, Serva’s CEO and founder. “We see this partnership with CNIC as a triple win for Serva, Canadian partners and patients in North American and around the world.”
Added Dr. Sarah Jones, Vice President of Serva Medical: “There is a long history in Canada of isotope production and a more recent reinvigoration and support for the industry. From universities to industry, reactors to radium supply, CNIC partners have been at the forefront of this dynamic work. We are honored to be part of this developing ecosystem of innovation and are eager to partner with CNIC members”.
About Serva Energy
Serva Energy is a nuclear innovation company revolutionizing the way radioisotopes and nuclear fuels are produced—serving the world critical cancer treatments and a safe carbon-free transition to a clean energy future. Serva fuel technologies aim to transform the state of nuclear power within this decade, while rapidly advancing the supply of needed radioisotopes for health care applications and biomedical research.
For more information about Serva Energy, please visit www.servaenergy.com
About the Canadian Nuclear Isotope Council
The CNIC is a coalition of science, healthcare and nuclear-sector organizations to ensure Canada remains a world leader in the production of life-saving isotopes by bringing awareness and supporting long-term policies at the domestic and international level that will save countless lives and support health-care innovation for decades to come.
To learn more about the CNIC visit www.CanadianIsotopes.ca and follow us on, Facebook, Twitter, and LinkedIn.
For more information, please contact:
Andrew Thiele
Executive Director
Canadian Nuclear Isotope Council
226-930-1869
Andrew.Thiele@brucepower.com